New long COVID clinical trials, FDA approves postpartum depression pill & RSV shot for babies

HHS forms the Office of Long COVID Research and Practice, and the NIH launches new Long COVID clinical trials. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses these new Long COVID developments, along with a study with insights into the maternal health crisis in the US and the FDA’s approval of a pill to treat postpartum depression. Plus, NIAID’s new director, the new head of the CDC and ACIP’s RSV shot recommendation for babies. American Medical Association CXO Todd Unger hosts. 🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan 🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew